Patrycja Bielawiec
Overview
Explore the profile of Patrycja Bielawiec including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bielawiec P, Harasim-Symbor E, Golaszewska K, Chabowski A, Hodun K, Sztolsztener K
PLoS One
. 2025 Mar;
20(3):e0315905.
PMID: 40036186
Atrial fibrillation (AF) has become the most common arrhythmia of clinical importance. A well-established and recommended therapeutic option for AF is the balloon-based cryoablation (CBA) method. There are still no...
2.
Harasim-Symbor E, Bielawiec P, Pedzinska-Betiuk A, Weresa J, Malinowska B, Konstantynowicz-Nowicka K, et al.
Nutr Metab Cardiovasc Dis
. 2024 Oct;
34(12):2817-2833.
PMID: 39358107
Background And Aims: Hypertension is a potent risk factor for cardiovascular diseases, which are the leading worldwide cause of death. Within time increased blood pressure (BP) induces cardiac contractile dysfunction,...
3.
Bielawiec P, Dziemitko S, Konstantynowicz-Nowicka K, Sztolsztener K, Chabowski A, Harasim-Symbor E
Front Mol Biosci
. 2024 Jun;
11:1401558.
PMID: 38919749
Numerous strategies have been proposed to minimize obesity-associated health effects, among which phytocannabinoids appear to be effective and safe compounds. In particular, cannabigerol (CBG) emerges as a potent modulator of...
4.
Bielawiec P, Dziemitko S, Konstantynowicz-Nowicka K, Chabowski A, Dzieciol J, Harasim-Symbor E
Sci Rep
. 2023 Mar;
13(1):3694.
PMID: 36879113
Obesity is one of the principal public health concerns leading to disturbances in glucose and lipid metabolism, which is a risk factor for several chronic diseases, including insulin resistance, type...
5.
Charytoniuk T, Sztolsztener K, Bielawiec P, Chabowski A, Konstantynowicz-Nowicka K, Harasim-Symbor E
Int J Mol Sci
. 2022 Feb;
23(4).
PMID: 35216351
It is known that metabolic disturbances, including obesity, predispose to an increased incidence of cardiovascular diseases. Elevated consumption of dietary fat results in intramyocardial accumulation of lipids and their biologically...
6.
Bielawiec P, Harasim-Symbor E, Sztolsztener K, Konstantynowicz-Nowicka K, Chabowski A
Nutrients
. 2021 Jun;
13(5).
PMID: 34064937
The consumption of fatty acids has increased drastically, exceeding the nutritional requirements of an individual and leading to numerous metabolic disorders. Recent data indicate a growing interest in using cannabidiol...
7.
Bielawiec P, Harasim-Symbor E, Konstantynowicz-Nowicka K, Sztolsztener K, Chabowski A
Biomolecules
. 2020 Aug;
10(9).
PMID: 32859125
Numerous studies showed that sustained obesity results in accumulation of bioactive lipid derivatives in several tissues, including skeletal muscle, which further contributes to the development of metabolic disturbances and insulin...
8.
Sztolsztener K, Chabowski A, Harasim-Symbor E, Bielawiec P, Konstantynowicz-Nowicka K
Biomolecules
. 2020 Aug;
10(8).
PMID: 32751983
Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease characterized by excessive lipid deposition. Lipid metabolism disturbances are possibly associated with hepatocyte inflammation development and oxidative balance impairment. The...
9.
Harasim-Symbor E, Polak-Iwaniuk A, Konstantynowicz-Nowicka K, Bielawiec P, Malinowska B, Kasacka I, et al.
Molecules
. 2020 Apr;
25(8).
PMID: 32326330
Hypertension coincides with myocardial alternations in lipid (including sphingolipids) and glucose metabolism. The latest data indicate that accumulation of metabolically active lipids, especially ceramide (CER) and diacylglycerol (DAG) significantly influences...
10.
Bielawiec P, Harasim-Symbor E, Chabowski A
Front Endocrinol (Lausanne)
. 2020 Mar;
11:114.
PMID: 32194509
Currently, an increasing number of diseases related to insulin resistance and obesity is an alarming problem worldwide. It is well-known that the above states can lead to the development of...